Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Hepatotoxicity Induced by "the 3Ks": Kava, Kratom and Khat.

Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, Terranova D, Busardò FP, Marinelli E.

Int J Mol Sci. 2016 Apr 16;17(4):580. doi: 10.3390/ijms17040580. Review.

2.

Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited.

Teschke R, Sarris J, Schweitzer I.

Br J Clin Pharmacol. 2012 Feb;73(2):170-4. doi: 10.1111/j.1365-2125.2011.04070.x.

3.

Kava Hepatotoxicity: Are we any closer to the truth?

Anke J, Ramzan I.

Planta Med. 2004 Mar;70(3):193-6. Review.

PMID:
15114493
4.

Contaminant hepatotoxins as culprits for kava hepatotoxicity--fact or fiction?

Teschke R, Sarris J, Lebot V.

Phytother Res. 2013 Mar;27(3):472-4. doi: 10.1002/ptr.4729. Epub 2012 May 14.

PMID:
22585547
5.

Kava hepatotoxicity: pathogenetic aspects and prospective considerations.

Teschke R.

Liver Int. 2010 Oct;30(9):1270-9. doi: 10.1111/j.1478-3231.2010.02308.x. Review.

PMID:
20630022
6.

Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster).

Martin AC, Johnston E, Xing C, Hegeman AD.

PLoS One. 2014 Nov 3;9(11):e111572. doi: 10.1371/journal.pone.0111572. eCollection 2014.

7.

Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.

Teschke R, Qiu SX, Xuan TD, Lebot V.

Phytother Res. 2011 Sep;25(9):1263-74. doi: 10.1002/ptr.3464. Epub 2011 Mar 28. Review.

PMID:
21442674
8.

Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?

Sarris J, Teschke R, Stough C, Scholey A, Schweitzer I.

Planta Med. 2011 Jan;77(2):107-10. doi: 10.1055/s-0030-1250290. Epub 2010 Sep 2.

PMID:
20814850
9.

The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Warner ML, Kaufman NC, Grundmann O.

Int J Legal Med. 2016 Jan;130(1):127-38. doi: 10.1007/s00414-015-1279-y. Epub 2015 Oct 28. Review.

PMID:
26511390
10.

Kava extracts: safety and risks including rare hepatotoxicity.

Teschke R, Gaus W, Loew D.

Phytomedicine. 2003;10(5):440-6. Review.

PMID:
12834011
11.

Kava hepatotoxicity: comparison of aqueous, ethanolic, acetonic kava extracts and kava-herbs mixtures.

Teschke R, Genthner A, Wolff A.

J Ethnopharmacol. 2009 Jun 25;123(3):378-84. doi: 10.1016/j.jep.2009.03.038. Epub 2009 Apr 5.

PMID:
19501269
13.
14.

In vitro study of the effects of khat (Catha edulis Forsk) extract on isolated mouse interstitial cells.

Nyongesa AW, Patel NB, Onyango DW, Wango EO, Odongo HO.

J Ethnopharmacol. 2007 Apr 4;110(3):401-5. Epub 2006 Oct 13.

PMID:
17113255
15.

Kava hepatotoxicity--a clinical review.

Teschke R.

Ann Hepatol. 2010 Jul-Sep;9(3):251-65. Review.

16.

Kava feeding in rats does not cause liver injury nor enhance galactosamine-induced hepatitis.

DiSilvestro RA, Zhang W, DiSilvestro DJ.

Food Chem Toxicol. 2007 Jul;45(7):1293-300. Epub 2007 Jan 26.

PMID:
17353074
17.

Kava hepatotoxicity: regulatory data selection and causality assessment.

Teschke R, Wolff A.

Dig Liver Dis. 2009 Dec;41(12):891-901. doi: 10.1016/j.dld.2009.04.003. Epub 2009 May 27.

PMID:
19477698
18.

Toxicity of kava kava.

Fu PP, Xia Q, Guo L, Yu H, Chan PC.

J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2008 Jan-Mar;26(1):89-112. doi: 10.1080/10590500801907407. Review.

19.

Effects of kava alkaloid, pipermethystine, and kavalactones on oxidative stress and cytochrome P450 in F-344 rats.

Lim ST, Dragull K, Tang CS, Bittenbender HC, Efird JT, Nerurkar PV.

Toxicol Sci. 2007 May;97(1):214-21. Epub 2007 Feb 27.

PMID:
17329236
20.

Hepatitis induced by Kava (Piper methysticum rhizoma).

Stickel F, Baumüller HM, Seitz K, Vasilakis D, Seitz G, Seitz HK, Schuppan D.

J Hepatol. 2003 Jul;39(1):62-7.

PMID:
12821045

Supplemental Content

Support Center